Please login to the form below

Not currently logged in
Email:
Password:

Medivir

This page shows the latest Medivir news and features for those working in and with pharma, biotech and healthcare.

RNA-focused biotech Storm Therapeutics raises extra £14m

RNA-focused biotech Storm Therapeutics raises extra £14m

STORM has also just hired  Mark Albertella as vice president of translational oncology.  Previously director of biology at Medivir, Albetella has a successful track record in oncology drug discovery and development

Latest news

More from news
Approximately 2 fully matching, plus 18 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

  • MISSION appoints Paul Wallace as chief business officer MISSION appoints Paul Wallace as chief business officer

    Joins from Medivir where he was executive VP and head of business development. ... During his time at Medivir, he played a key role in the execution of over 25 partnership deals, eight products were taken into clinical development and two drugs were

  • Medivir names new CEO Medivir names new CEO

    Niklas will in particular be able to contribute and strengthen Medivir in the important areas of strategic business development and commercialisation.”. ... An update of Medivir's strategic plan is the number one priority, and work on this is already

More from appointments
Approximately 1 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Market Access Transformation

Founded in 201, Market Access Transformation (MAT) specializes in developing agile technology platforms that enable the healthcare community to exchange...

Latest intelligence

Diversity in clinical trials: looking back at our 2021 blogs
In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...